Novartis AG Strikes a Groundbreaking Deal to Acquire Regulus Therapeutics for Up to $1.7 Billion
Novartis AG announces a deal to acquire Regulus Therapeutics for up to $1.7 billion, including an initial $0.8 billion payment and a contingent value right for shareholders, aiming...